[CIS PIDD] CGD and cutaneous ulcers

[Juan Carlos Aldave Becerra]

En endocrino el protocolo era con células madre, no sé si hay otro con G-CSF. Se diluye G-CSF en 50 mL de agua destilada para lograr una concentración de 5 ug/mL y se aplican gasas empapadas 3 veces al día. Se puede guardar el preparado por 2 semanas a 4 grados en la refri. 

Juan Carlos Aldave, MD
Allergy and Clinical Immunology
Rebagliati Martins National Hospital - Lima, Peru
Primary Immunodeficiency Committee of the Latin American Association of Immunology
WAO Special Committee on Eosinophil and Mast Cell Disorders
Clinical Immunology Committee of the IUIS

Date: Fri, 10 Aug 2012 22:55:31 -0500
From: wilmer.cordova at gmail.com
To: pagid at list.clinimmsoc.org
Subject: Re: [CIS PIDD] CGD and cutaneous ulcers

Gracias Juan estaré procesando la información y con alguna propuesta en reba en endocrino hay un protocolo con un Dr. oriental en pie diabético con FSC G. puedes averiguar si ellos usan algo tópico y cómo lo usan para poder aprovechar su experiencia?


2012/8/10 Juan Carlos Aldave Becerra <jucapul_84 at hotmail.com>





Dear Sara, what is the application method and frequency of treatment?
I have a patient with CGD and cutaneous ulcers. In Peru we only have G-CSF, may it replace GM-CSF?
Kind regards,


Juan Carlos Aldave, MD
Allergy and Clinical Immunology
Rebagliati Martins National Hospital - Lima, Peru
Peruvian Group for Primary Immunodeficiencies
WAO Special Committee on Eosinophil and Mast Cell Disorders
Clinical Immunology Committee of the IUIS

From: sleo at cw.bc.ca
To: pagid at list.clinimmsoc.org

Date: Fri, 10 Aug 2012 14:18:16 -0700
Subject: [CIS PIDD] CGD and cutaneous ulcers








Dear Colleagues,


My name is Sara Leo and I'm a 2nd year Pediatric Immunology/Allergy fellow at BC Children's Hospital in Vancouver, BC. About a year ago, Dr. Stuart Turvey wrote to PAGID to see if anyone had experience with using topical GM-CSF to treat CGD patients with cutaneous
 ulcers. Since then, we have successfully treated our patient with topical GM-CSF. We would like to put together a case series of CGD patients with cutaneous ulcers that have been treated with topical GM-CSF and would be interested in hearing about both failed
 and successful regimens. If anyone has experience with the above and would like to collaborate with us, we would love to hear from you.


Yours Sincerely,

Sara 
 



Sara Leo BSc, MD, FRCPC

Pediatric Clinical Immunology and Allergy, PGY-5

University of British Columbia
BC Children's Hospital

Email: sleo at cw.bc.ca

Pager: 410-1447



 		 	   		  


-- 
Atte 
Wilmer CórdovaInmunología Alergología
Instituto Nacional de Salud del Niño - Perú
http://www.isn.gob.pe
 		 	   		  
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/pipermail/pagid/attachments/20120811/13fd15e7/attachment-0001.htm>